Salvage TherapyRadiotherapyRadiotherapy, ConformalRadiotherapy, AdjuvantProstatectomyPelvic NeoplasmsRadiotherapy DosagePelvisCombined Modality TherapyProstate-Specific AntigenRadiation InjuriesProstatic NeoplasmsChemotherapy, AdjuvantAdjuvants, ImmunologicDisease-Free SurvivalRadiotherapy, Intensity-ModulatedRadiotherapy Planning, Computer-AssistedRectal NeoplasmsRadiotherapy, High-EnergyBrachytherapyAntidiarrhealsRetrospective StudiesTreatment OutcomeRadiation DosageDose FractionationDose-Response Relationship, RadiationAntineoplastic Combined Chemotherapy ProtocolsNeoplasm StagingFreund's AdjuvantUterine Cervical NeoplasmsRadiation, IonizingRadiotherapy, Computer-AssistedCisplatinRadiotherapy, Image-GuidedRadiation OncologyRadiation ToleranceNeoplasm Recurrence, LocalLimb SalvageProportional Hazards ModelsAdenocarcinomaRadiosurgeryBreast NeoplasmsHead and Neck NeoplasmsSurvival AnalysisSurvival RateFollow-Up StudiesPrognosisAdjuvants, PharmaceuticChemoradiotherapyRadiationBrain NeoplasmsRadiation ProtectionRadiation PneumonitisRadiation-Sensitizing AgentsFluorouracilCarcinoma, Squamous CellRadiometryNeoplasms, Radiation-InducedNasopharyngeal NeoplasmsTime FactorsRadiation MonitoringOrgans at RiskLung NeoplasmsAntineoplastic AgentsParticle AcceleratorsCranial IrradiationRadiodermatitisMastectomy, SegmentalNeoadjuvant TherapyHodgkin DiseaseTomography, X-Ray ComputedDacarbazineCyclophosphamideVincristineRadiation-Protective AgentsNeoplasms, Second PrimaryLaryngeal NeoplasmsLymphatic MetastasisNeoplasmsKaplan-Meier EstimateDihydroxyacetoneCobalt RadioisotopesDoxorubicinMastectomyAntineoplastic Agents, HormonalProcarbazineGamma RaysOrgan Sparing TreatmentsCortodoxoneDrug Administration ScheduleCarcinoma, Non-Small-Cell LungHeavy Ion RadiotherapySarcomaGlioblastomaCarcinomaXerostomiaAntineoplastic Agents, AlkylatingLymphatic IrradiationAluminum HydroxideRadioisotope Teletherapy